Ahmet Acar

2.3k total citations · 1 hit paper
34 papers, 1.4k citations indexed

About

Ahmet Acar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ahmet Acar has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Ahmet Acar's work include Cancer Genomics and Diagnostics (9 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (4 papers). Ahmet Acar is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (4 papers). Ahmet Acar collaborates with scholars based in Türkiye, United Kingdom and United States. Ahmet Acar's co-authors include Akira Orimo, Robert A. Weinberg, Ittai Ben‐Porath, Andrea L. Richardson, Tamer T. Önder, Christina Scheel, Kieran T. Mellody, Zhigang C. Wang, Elinor Ng Eaton and Yasushi Kojima and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Ahmet Acar

32 papers receiving 1.3k citations

Hit Papers

Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1)... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmet Acar Türkiye 14 728 660 388 221 152 34 1.4k
Randolph S. Watnick United States 16 662 0.9× 788 1.2× 398 1.0× 255 1.2× 81 0.5× 27 1.4k
Jean‐Gabriel Judde France 19 946 1.3× 581 0.9× 363 0.9× 223 1.0× 115 0.8× 42 1.5k
Despina Siolas United States 8 465 0.6× 674 1.0× 301 0.8× 188 0.9× 145 1.0× 21 1.2k
Yongping Crawford United States 14 581 0.8× 1.1k 1.7× 450 1.2× 157 0.7× 141 0.9× 16 1.5k
Andrea Richardson United States 9 849 1.2× 646 1.0× 439 1.1× 117 0.5× 156 1.0× 12 1.4k
Alison Cheung Canada 14 684 0.9× 1.3k 2.0× 488 1.3× 113 0.5× 162 1.1× 26 1.9k
Yves Hüsemann Germany 4 716 1.0× 415 0.6× 415 1.1× 147 0.7× 72 0.5× 4 1.0k
Pedro P. López‐Casas Spain 25 978 1.3× 702 1.1× 540 1.4× 317 1.4× 104 0.7× 52 1.8k
Shivani Patel United States 9 1.1k 1.5× 1.1k 1.7× 495 1.3× 126 0.6× 93 0.6× 25 1.8k
Kathleen Lambein Belgium 18 743 1.0× 578 0.9× 427 1.1× 363 1.6× 49 0.3× 41 1.5k

Countries citing papers authored by Ahmet Acar

Since Specialization
Citations

This map shows the geographic impact of Ahmet Acar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Acar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Acar more than expected).

Fields of papers citing papers by Ahmet Acar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmet Acar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Acar. The network helps show where Ahmet Acar may publish in the future.

Co-authorship network of co-authors of Ahmet Acar

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmet Acar. A scholar is included among the top collaborators of Ahmet Acar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmet Acar. Ahmet Acar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliveira, Érica A., Javier Fernández-Mateos, George D. Cresswell, et al.. (2025). Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm. Cancer Research. 85(15). 2921–2938. 1 indexed citations
2.
Acar, Ahmet, et al.. (2025). Molecular insights into genodermatoses: Genetic findings from 43 patients. Archives of Dermatological Research. 317(1). 512–512. 1 indexed citations
4.
Aydın, Sevtap, et al.. (2025). Benchmarking long-read structural variant calling tools and combinations for detecting somatic variants in cancer genomes. Scientific Reports. 15(1). 8707–8707. 3 indexed citations
5.
6.
Pathak, Surajit, Vignesh Palani, Ahmet Acar, et al.. (2024). Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach. Biomedicines. 12(1). 217–217. 11 indexed citations
7.
Acar, Ahmet. (2023). Integrative profiling of CEACAM1 in different malignancies with implications on the SARS-CoV-2 infection genes ACE2 and TMPRSS2. OpenMETU (Middle East Technical University). 51(2). 215–225. 2 indexed citations
8.
Acar, Ahmet, et al.. (2023). Investigation of evolutionary dynamics for drug resistance in 3D spheroid model system using cellular barcoding technology. PLoS ONE. 18(9). e0291942–e0291942. 3 indexed citations
9.
Zapata, Luís, Giulio Caravagna, Marc Williams, et al.. (2023). Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. Nature Genetics. 55(3). 451–460. 34 indexed citations
10.
Acar, Ahmet. (2023). Pan-Cancer Analysis of the COVID-19 Causal Gene SLC6A20. ACS Omega. 8(14). 13153–13161. 4 indexed citations
11.
Acar, Ahmet, et al.. (2022). Penetrance of Gastric Adenocarcinoma Susceptibility Genes: A Systematic Review. Annals of Surgical Oncology. 30(3). 1795–1807. 1 indexed citations
12.
Acar, Ahmet, et al.. (2022). Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers. Scientific Reports. 12(1). 11763–11763. 14 indexed citations
13.
Acar, Ahmet, Ana Hidalgo‐Sastre, Michael K. Leverentz, et al.. (2021). Inhibition of Wnt signalling by Notch via two distinct mechanisms. Scientific Reports. 11(1). 9096–9096. 44 indexed citations
14.
Acar, Ahmet, Daniel Nichol, Javier Fernández-Mateos, et al.. (2020). Exploiting evolutionary steering to induce collateral drug sensitivity in cancer. Nature Communications. 11(1). 1923–1923. 70 indexed citations
15.
Caravagna, Giulio, Timon Heide, Marc Williams, et al.. (2020). Subclonal reconstruction of tumors by using machine learning and population genetics. Nature Genetics. 52(9). 898–907. 57 indexed citations
16.
Spiteri, Inmaculada, Giulio Caravagna, George D. Cresswell, et al.. (2018). Evolutionary dynamics of residual disease in human glioblastoma. Annals of Oncology. 30(3). 456–463. 45 indexed citations
17.
Cintolo-Gonzalez, Jessica, Danielle Braun, Amanda L. Blackford, et al.. (2017). Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Research and Treatment. 164(2). 263–284. 119 indexed citations
18.
Acar, Ahmet, Bruno M. Simões, Robert B. Clarke, & Keith Brennan. (2016). A Role for Notch Signalling in Breast Cancer and Endocrine Resistance. Stem Cells International. 2016(1). 2498764–2498764. 53 indexed citations
20.
Polanska, Urszula M., Ahmet Acar, & Akira Orimo. (2011). Experimental Generation of Carcinoma-Associated Fibroblasts (CAFs) from Human Mammary Fibroblasts. Journal of Visualized Experiments. e3201–e3201. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026